Evaluation of the synergistic potential of vancomycin combined with other antimicrobial agents against methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus spp strains

被引:34
作者
da Silva, Livia Viganor [1 ]
Araujo, Manuela Tedesco [1 ]
Netto dos Santos, Katia Regina [2 ]
Ferreira Nunes, Ana Paula [1 ]
机构
[1] Univ Fed Espirito Santo, Dept Patol, Lab Resistencia Bacteriana, Vitoria, ES, Brazil
[2] Univ Fed Rio de Janeiro, Dept Med Microbiol, Lab Infeccao Hosp, Rio De Janeiro, Brazil
来源
MEMORIAS DO INSTITUTO OSWALDO CRUZ | 2011年 / 106卷 / 01期
关键词
MRSA; MRCNS; vancomycin; synergism; checkerboard; time-kill curve; IN-VITRO; BETA-LACTAMS; INFECTIONS; COMBINATION; IMIPENEM; THERAPY; VIVO; MRSA;
D O I
10.1590/S0074-02762011000100007
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Methicillin-resistant Staphylococcus aureus (MRSA) and coagulase-negative Staphylococcus spp (CNS) are the most common pathogens that cause serious long term infections in patients. Despite the existence of new antimicrobial agents, such as linezolid, vancomycin (VAN) remains the standard therapy for the treatment of infections caused by these multidrug-resistant strains. However, the use of VAN has been associated with a high frequency of therapeutic failures in some clinical scenarios, mainly with decreasing concentration of VAN. This work aims to evaluate the synergic potential of VAN plus sulfamethoxazole/trimethoprim (SXT), VAN plus rifampin (RIF) and VAN plus imipenem (IPM) in sub-minimum inhibitory concentrations against 22 clinical strains of MRSA and CNS. The checkerboard method showed synergism of VAN/RIF and VAN/SXT against two and three of the 22 strains, respectively. The combination of VAN with IPM showed synergistic effects against 21 out of 22 strains by the E-test method. Four strains were analyzed by the time-kill curve method and synergistic activity was observed with VAN/SXT, VAN/RIF and especially VAN/IPM in sub-inhibitory concentrations. It would be interesting to determine if synergy occurs in vivo. Evidence of in vivo synergy could lead to a reduction of the standard VAN dosage or treatment time.
引用
收藏
页码:44 / 50
页数:7
相关论文
共 22 条
[1]   In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin [J].
Alou, L ;
Cafini, F ;
Sevillano, D ;
Unzueta, I ;
Prieto, J .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 23 (05) :513-516
[2]  
[Anonymous], 2009, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically
[3]  
Approved Standard, VEighth
[4]  
Brunton LL, 2006, Goodman and Gilman's The Pharmacological Basis of Therapeutics, V11th
[5]   Antibiotics - an investment worth making? [J].
Christoffersen, Ralph E. .
NATURE BIOTECHNOLOGY, 2006, 24 (12) :1512-1514
[6]   Use of Vancomycin in Pediatrics [J].
Dehority, Walter .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2010, 29 (05) :462-464
[7]  
FRAME PT, 1984, J NEUROSURG, V60, P354, DOI 10.3171/jns.1984.60.2.0354
[8]   Vancomycin-Associated Nephrotoxicity: Grave Concern or Death by Character Assassination? [J].
Hazlewood, Kathleen A. ;
Brouse, Sara D. ;
Pitcher, William D. ;
Hall, Ronald G. .
AMERICAN JOURNAL OF MEDICINE, 2010, 123 (02) :182.e1-182.e7
[9]   Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007 [J].
Hidron, Alicia I. ;
Edwards, Jonathan R. ;
Patel, Jean ;
Horan, Teresa C. ;
Sievert, Dawn M. ;
Pollock, Daniel A. ;
Fridkin, Scott K. .
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2008, 29 (11) :996-1011
[10]   In vitro and in vivo synergistic activities of linezolid combined with subinhibitory concentrations of imipenem against methicillin-resistant Staphylococcus aureus [J].
Jacqueline, C ;
Navas, D ;
Batard, E ;
Miegeville, AF ;
Le Mabecque, V ;
Kergueris, MF ;
Bugnon, D ;
Potel, G ;
Caillon, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :45-51